Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 51464 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 53050 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 55526 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 58996 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 67047 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 69859 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 74382 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 75596 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 92498 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 92581 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 95260 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 114598 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 131015 | Peak area | HAHA | Untreated |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 198877 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 198924 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 6394 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 8000 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 10445 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 11475 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 12828 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 14444 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 15107 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 15223 | Peak area | HAHA | IL-17A |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 15792 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 21548 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 22369 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 27200 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 36560 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | Peak area | PAK | IL-17A | |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | Peak area | PAK | Untreated |